Picture a living cell as if it were a city. If you were the urban planner for this (very little, very alive) city, one of the ...

The question of how life could have emerged is one of the most long-standing mysteries in science. In a new study, the ...

The Path of Exile 3.26 Secrets of the Atlas update is revealed, with more endgame pinnacle bosses, new crafting options, and ...

ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial of its next-generation CD47-targeting antibody, IMC-002, in combination with ...

Clinical validation of the Azymetric platform is demonstrated by the accelerated approval our partner Jazz Pharmaceuticals received from the U.S. Food and Drug Administration in 2024 for Ziihera® ...

Vigil’s shareholders to receive up to $10.00 per share in cash, comprised of $8.00 per share in cash at closing and a non-tradeable contingent value right of $2.00 per share in cash following the ...

The small incursion targets the Belgorod region, according to Ukrainian officials, analysts of open-source intelligence and Russian military bloggers. The advance comes as cease-fire talks ...

ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial ...

ABSTRACT: Neutrophils, crucial players in the effector phase of the immune response, are recognized as important mediators of both innate and adaptive immune responses. Through the production of pro- ...

1 Phase 1b interim data demonstrate that IO ... dependent cellular cytotoxicity and antibody-dependent cellular phagocytosis. Study enrollment is ongoing, and additional clinical data will be ...

Phagocytosis includes the smell, eating and digestion phases. Notably, efficient phagocytosis critically depends on phagocyte capacity to take up dead cells continually due to the limited number of ...